Tandem Health Raises $100M Series B

Tandem Health, a European healthtech company providing AI-powered clinical assistance, has raised $100 million in Series B funding. This latest round brings the company's total funding to $160 million.

Investors

The funding round was led by the Scaleup Europe Fund, managed by EQT, marking the fund's first investment in the healthcare sector. Additional participants in the round include existing investors Kinnevik, Northzone, Amino Collective, and Visionaries.

Tandem Health Use of Funds

Tandem Health plans to use the new capital to accelerate the adoption of AI across European healthcare markets. The company will focus on evolving its existing AI Medical Assistant into an AI-native Clinic Operating System and expanding its operational footprint across its 14 active European markets.

About Tandem Health

Led by CEO Lukas Saari, Tandem Health is dedicated to alleviating administrative burdens for clinicians through clinically safe, regulatory-grade AI technology. Its product suite includes an AI scribe, coding assistant, and clinical decision support tools, which are certified as Class IIa medical devices under EU regulations. The platform is currently utilized by 10,000 care organizations across Europe.

Funding Details

Company Website: https://tandemhealth.ai

Company: Tandem Health
Raised: $100M
Round: Series B
Funding Date: September 14, 2026
Lead Investor: Scaleup Europe Fund (managed by EQT)
Additional Investors: Kinnevik, Northzone, Amino Collective, Visionaries
Company Website: https://tandemhealth.ai
Software Category: Healthtech
Source: https://tandemhealth.ai/resources/news/tandem-health-raises-100m-to-bring-european-healthcare-into-the-ai-era-led-by-the-scaleup-europe-fund-managed-by-eqt